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• PRIMARY OBJECTIVE: 
• To assess the changes in coagulation profile 
following snake bite.
• 2.   To analyse the time intervals between the 
snake bite and onset of coagulation profile to       
normal
• INTRODUCTION
• Snake bite is one of the common medical emergencies encountered 
in day to day practice in India. The morbidity and mortality rates of 
snake bite patients is high .236 species of snakes have been 
identified in India out of which 52 are poisonous. Most of the snake 
bites occur in fields, mostly in rainy season. 
• Currently intensive work is being done on the pharmacological, 
pathological toxicological and immunological aspects of snake 
venoms to give a better break to the snake bite victim ,which has 
resulted in the production of polyvalent and monovalent anti snake 
venoms. 
• The incidence of snakebite in CHENNAI and surrounding area is 
high. Snake bite is completely treatable. Immediate steps should be 
taken to shift the victim to the hospital as early as possible and it 
can be prevented to a certain extent educating people 
• INCLUSION CRITERIA
• All patients more than 12 completed years of 
age with history of snake bites and with at least 
one of following  criteria will be  included in the 
study --
• 1.  Patients or attenders have seen the offending 
snake.and bitten .
• 2.  Definite fang marks noted.
• 3.  Features of local or systemic envenomation
• Exclusion criteria 
• Patients with history of suspected snake bite where in,
• 1.  Patient or attenders have not seen the snake.
• 2.  No fang marks.
• 3.  No features of envenomation.
• 4.Pts with pre-existing coagulopathy,on anticoagulants and antiplatelet drugs,h/o renal disease.
• Pts with risk factors like Diabetes,Hypertension,Connective tissue disease,chronic infection.
• Mode of selection – By simple random method.
• Sample size – 100  cases
• DURATION: 6months 
• INVESTIGATIONS: Sampling Technique
• INVESTIGATIONS
• CBC
• RENAL FUNCTION TEST(UREA CREATENINE)
• URINE ROUTINE AND MICROSCOPY
• COAUGULATION PROFILE(BT,PT,INR,CT)..
• LIVER FUNCTION TEST
• ECG
• METHODOLOGY
• After screening patient who fulfil  inclusion criteria, willing 
to participate in trial and sign consent letter .Patient will be 
screened as per protocol .Prior h/o snake bite will be 
enquired..lab investigations will be done like bleeding time, 
clotting time.Prothrombin time and activated partial 
thromboplatsin time(when required) will be analysed using 
automated analysis.Serum fibrinogen and fibrin 
degradation products (FDP)will be determined when 
indicated.For Serum fibrinogen ammonium sulphate 
reagent will be used.
• STATISTICAL ANALYSIS  Will be done SPSS SOFTWARE.
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